Genotoxicity of acrylamide in vitro: Acrylamide is not metabolically activated in standard in vitro systems

DOI Web Site Web Site PubMed 被引用文献5件

書誌事項

公開日
2011-01
権利情報
  • http://onlinelibrary.wiley.com/termsAndConditions#vor
DOI
  • 10.1002/em.20560
公開者
Wiley

この論文をさがす

説明

<jats:title>Abstract</jats:title><jats:p>The recent finding that acrylamide (AA), a genotoxic rodent carcinogen, is formed during the frying or baking of a variety of foods raises human health concerns. AA is known to be metabolized by cytochrome P450 2E1 (CYP2E1) to glycidamide (GA), which is responsible for AA's in vivo genotoxicity and probable carcinogenicity. In in‐vitro mammalian cell tests, however, AA genotoxicity is not enhanced by rat liver S9 or a human liver microsomal fraction. In an attempt to demonstrate the in vitro expression of AA genotoxicity, we employed<jats:italic>Salmonella</jats:italic>strains and human cell lines that overexpress human CYP2E1. In the<jats:italic>umu</jats:italic>test, however, AA was not genotoxic in the CYP2E1‐expressing<jats:italic>Salmonella</jats:italic>strain or its parental strain. Moreover, a transgenic human lymphoblastoid cell line overexpressing CYP2E1 (h2E1v2) and its parental cell line (AHH‐1) both showed equally weak cytotoxic and genotoxic responses to high (>1 mM) AA concentrations. The DNA adduct N7‐GA‐Gua, which is detected in liver following AA treatment in vivo, was not substantially formed in the in vitro system. These results indicate that AA was not metabolically activated to GA in vitro. Thus, AA is not relevantly genotoxic in vitro, although its in vivo genotoxicity was clearly demonstrated. Environ. Mol. Mutagen. 52:11–19, 2011. © 2010 Wiley‐Liss, Inc.</jats:p>

収録刊行物

被引用文献 (5)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ